Odyssey Therapeutics, Inc. (ODTX)
Nasdaq: ODTX · CIK 0001882782 · United States
Every official Odyssey Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open ODTX filings
Odyssey Therapeutics, Inc. documents
- Odyssey Therapeutics, Inc. 10-K 2026ODTX 10-K 2026: annual report for fiscal 2026
- Odyssey Therapeutics, Inc. 10-K 2025ODTX 10-K 2025: annual report for fiscal 2025
- Odyssey Therapeutics, Inc. 10-K 2024ODTX 10-K 2024: annual report for fiscal 2024
- Odyssey Therapeutics, Inc. 10-K 2023ODTX 10-K 2023: annual report for fiscal 2023
- Odyssey Therapeutics, Inc. 10-K 2022ODTX 10-K 2022: annual report for fiscal 2022
- Odyssey Therapeutics, Inc. 10-Q 2026ODTX 10-Q 2026: quarterly report for fiscal 2026
- Odyssey Therapeutics, Inc. 10-Q 2025ODTX 10-Q 2025: quarterly report for fiscal 2025
- Odyssey Therapeutics, Inc. 10-Q 2024ODTX 10-Q 2024: quarterly report for fiscal 2024
- Odyssey Therapeutics, Inc. 10-Q 2023ODTX 10-Q 2023: quarterly report for fiscal 2023
- Odyssey Therapeutics, Inc. 10-Q 2022ODTX 10-Q 2022: quarterly report for fiscal 2022
- Odyssey Therapeutics, Inc. 8-K 2026ODTX 8-K 2026: current report for fiscal 2026
- Odyssey Therapeutics, Inc. 8-K 2025ODTX 8-K 2025: current report for fiscal 2025
- Odyssey Therapeutics, Inc. 8-K 2024ODTX 8-K 2024: current report for fiscal 2024
- Odyssey Therapeutics, Inc. 8-K 2023ODTX 8-K 2023: current report for fiscal 2023
- Odyssey Therapeutics, Inc. 8-K 2022ODTX 8-K 2022: current report for fiscal 2022
- Odyssey Therapeutics, Inc. DEF 14A 2026ODTX DEF 14A 2026: proxy statement for fiscal 2026
- Odyssey Therapeutics, Inc. DEF 14A 2025ODTX DEF 14A 2025: proxy statement for fiscal 2025
- Odyssey Therapeutics, Inc. DEF 14A 2024ODTX DEF 14A 2024: proxy statement for fiscal 2024
- Odyssey Therapeutics, Inc. DEF 14A 2023ODTX DEF 14A 2023: proxy statement for fiscal 2023
- Odyssey Therapeutics, Inc. DEF 14A 2022ODTX DEF 14A 2022: proxy statement for fiscal 2022
- Odyssey Therapeutics, Inc. Form 4 2026ODTX Form 4 2026: insider trading filing for fiscal 2026
- Odyssey Therapeutics, Inc. Form 4 2025ODTX Form 4 2025: insider trading filing for fiscal 2025
- Odyssey Therapeutics, Inc. Form 4 2024ODTX Form 4 2024: insider trading filing for fiscal 2024
- Odyssey Therapeutics, Inc. Form 4 2023ODTX Form 4 2023: insider trading filing for fiscal 2023
- Odyssey Therapeutics, Inc. Form 4 2022ODTX Form 4 2022: insider trading filing for fiscal 2022
- Odyssey Therapeutics, Inc. S-1 2026ODTX S-1 2026: registration statement for fiscal 2026
- Odyssey Therapeutics, Inc. S-1 2025ODTX S-1 2025: registration statement for fiscal 2025
- Odyssey Therapeutics, Inc. S-1 2024ODTX S-1 2024: registration statement for fiscal 2024
- Odyssey Therapeutics, Inc. S-1 2023ODTX S-1 2023: registration statement for fiscal 2023
- Odyssey Therapeutics, Inc. S-1 2022ODTX S-1 2022: registration statement for fiscal 2022
- Odyssey Therapeutics, Inc. 13F 2026ODTX 13F 2026: institutional holdings for fiscal 2026
- Odyssey Therapeutics, Inc. 13F 2025ODTX 13F 2025: institutional holdings for fiscal 2025
- Odyssey Therapeutics, Inc. 13F 2024ODTX 13F 2024: institutional holdings for fiscal 2024
- Odyssey Therapeutics, Inc. 13F 2023ODTX 13F 2023: institutional holdings for fiscal 2023
- Odyssey Therapeutics, Inc. 13F 2022ODTX 13F 2022: institutional holdings for fiscal 2022
More companies